Specify a stock or a cryptocurrency in the search bar to get a summary
Chemclin Diagnostics Co. Ltd. A
688468Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China. Address: Incubator Building, 1st and 6th Floors, Beijing, China, 100094
Analytics
WallStreet Target Price
–P/E ratio
18.8649Dividend Yield
1.87 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688468
Dividend Analytics 688468
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
69 %Dividend History 688468
Stock Valuation 688468
Financials 688468
Results | 2019 | Dynamics |